SLGL — Sol-Gel Technologies Ltd.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1684693 · Israel
Last close
$52.83
Market Cap
$172.97M
52W High
$97.97
52W Low
$32.51
ADV30
37,887
Next earnings
2026-11-12

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 41,000 — -6,105,000 -5,622,000 50,202,000 13,094,000 7,392,000
Jun 2026 591,000 — -4,162,000 -3,681,000 53,756,000 16,662,000 5,660,000
Mar 2026 108,000 — -3,855,000 -3,727,000 58,550,000 10,136,000 7,144,000
Dec 2025 696,000 — -3,411,000 -2,987,000 29,917,000 11,033,000 7,106,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-244,418,000
Inventory
—
Receivables
$713,000
ST Investments
$31,267,000
EBIT TTM
$-17,716,000
Pretax Income TTM
$-16,337,000
Interest Exp TTM
—
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,795,000
EBITDA
$-17,690,000
Free Cash Flow
$-2,120,250
Enterprise Value
$168,728,496
Total Cash
$47,929,000
Total Debt
$770,000
Shares Out
3,273,999
Trailing EPS
$-5.62
Book Value
$14.69
ROE
-40.9%
ROA
-23.9%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 19,388,000 -7,538,000 -6,127,000 29,917,000 7,106,000 22,811,000 322,000
Dec 2024 11,538,000 -12,014,000 -10,580,000 35,846,000 6,996,000 28,850,000 -13,889,000
Dec 2023 1,554,000 -29,305,000 -27,238,000 45,287,000 6,643,000 38,644,000 -17,730,000
Dec 2022 3,883,000 -16,244,000 -14,923,000 46,628,000 4,415,000 42,213,000 -9,484,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-7.70

Peers — same industry

TickerNameMarket CapLastDaily %
PYXS Pyxis Oncology, Inc. $172.24M $1.44 —
IFRX InflaRx N.V. $169.47M $1.15 —
KRRO Korro Bio, Inc. $169.10M $12.32 —
ORMP ORAMED PHARMACEUTICALS INC. $168.29M $3.87 —
ELDN Eledon Pharmaceuticals, Inc. $167.23M $1.98 —

News headlines (Yahoo Finance, 1h cache)

Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Misses Revenue Estimates
2026-11-12 13:40 · Yahoo
Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
2026-11-12 13:30 · Yahoo
Sol-Gel Eyes 2028 Launch as SGT-610 Nears Pivotal Gorlin Syndrome Data
2026-10-15 03:02 · Yahoo
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
2026-09-30 13:14 · Yahoo
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
2026-09-17 12:30 · Yahoo
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
2026-08-20 12:30 · Yahoo
Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates
2026-10-29 22:05 · Yahoo
New Strong Buy Stocks for October 16th
2026-10-16 07:04 · Yahoo
SolGel Technologies (SLGL) Upgraded to Buy: Here's Why
2026-10-08 15:00 · Yahoo
SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
2026-09-17 13:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.